Aslan Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-UBS Group AG directly and on behalf of certain subsidiaries.(8.91%)
Aslan Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-UBS Group AG directly and on behalf of certain subsidiaries.(8.91%)
Aslan Pharmaceuticals | SC 13G：超過5%持股股東披露文件-UBS Group AG directly and on behalf of certain subsidiaries.(8.91%)
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。